Cargando…
Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
BACKGROUND: Although metreleptin replacement therapy was shown to improve metabolic alterations in lipodystrophic syndromes, patients’ adherence and satisfaction with treatment have never been evaluated. The 20 patients with lipodystrophic syndromes participating in the French compassionate program...
Autores principales: | Vatier, Camille, Kalbasi, Dina, Vantyghem, Marie-Christine, Lascols, Olivier, Jéru, Isabelle, Daguenel, Anne, Gautier, Jean-François, Buyse, Marion, Vigouroux, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626409/ https://www.ncbi.nlm.nih.gov/pubmed/31300002 http://dx.doi.org/10.1186/s13023-019-1141-2 |
Ejemplares similares
-
SUN-037 Diagnosis Challenge in Type 4 Familial Partial Lipodystrophic Syndrome
por: Vantyghem, Marie-Christine, et al.
Publicado: (2019) -
Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015) -
Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
por: Vigouroux, Corinne, et al.
Publicado: (2018) -
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
por: Mosbah, Héléna, et al.
Publicado: (2022) -
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)